Oculis Holding AG (OCS) Change in Accured Expenses (2024 - 2025)
Oculis Holding AG (OCS) recorded quarterly Change in Accured Expenses of -$334787.4 in Q1 2025, up 92.96% quarter-over-quarter from -$4.8 million in Q1 2024, and up 92.96% on a YoY basis from -$173500.6 in Q1 2024.
Oculis Holding AG (OCS) Change in Accured Expenses (2024 - 2025) Analysis & Trends
Oculis Holding AG's Change in Accured Expenses history runs 2 years deep, the most recent figure standing at -$334787.4 for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -334,787.41 |
| Mar 31, 2025 | -334,787.41 |
| Mar 31, 2024 | -4.76 Mn |
| Mar 31, 2024 | -4.76 Mn |